S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AKYA Akoya BioSciences Inc

3.93

-0.03 (-0.76%)

Last Updated: 09:23:50

Delayed by 15 minutes

Akoya Biosciences, Bio-Techne team up to develop spatial multiomics workflow

To read the full story on Seeking Alpha, click here.

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Akoya BioSciences Charts.

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Akoya BioSciences Charts.

Akoya BioSciences Inc News

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
Thursday 2 May 2024 (3 hours ago) • GlobeNewswire Inc.

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
Monday 22 April 2024 (1 week ago) • GlobeNewswire Inc.

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
Friday 5 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
Monday 4 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
Thursday 8 February 2024 (3 months ago) • GlobeNewswire Inc.

More Akoya BioSciences Inc News Articles

Global Developments (PK)

Atacama Resources (PK)

NaturalShrimp (QB)

Mullen Automotive

Verb Technology

International Star (PK)

Federal Home Loan Mortgage (QB)

FBEC Worldwide (PK)

Moon Equity (PK)

Auto Parts 4Less (PK)

NioCorp Developments

Globestar Therapeutics (PK)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions